GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aelis Farma SA (XPAR:AELIS) » Definitions » Days Payable

Aelis Farma (XPAR:AELIS) Days Payable : 0.00 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Aelis Farma Days Payable?

Aelis Farma's average Accounts Payable for the six months ended in Dec. 2023 was €3.94 Mil. Aelis Farma's Cost of Goods Sold for the six months ended in Dec. 2023 was €0.00 Mil.

The historical rank and industry rank for Aelis Farma's Days Payable or its related term are showing as below:

XPAR:AELIS's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 148.28
* Ranked among companies with meaningful Days Payable only.

Aelis Farma's Days Payable stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).


Aelis Farma Days Payable Historical Data

The historical data trend for Aelis Farma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aelis Farma Days Payable Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial - - - - -

Aelis Farma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Aelis Farma's Days Payable

For the Biotechnology subindustry, Aelis Farma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aelis Farma's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aelis Farma's Days Payable distribution charts can be found below:

* The bar in red indicates where Aelis Farma's Days Payable falls into.



Aelis Farma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Aelis Farma's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (2.415 + 4.495) / 2 ) / 0*365
=3.455 / 0*365
=N/A

Aelis Farma's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (3.387 + 4.495) / 2 ) / 0*365 / 2
=3.941 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aelis Farma Days Payable Related Terms

Thank you for viewing the detailed overview of Aelis Farma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Aelis Farma (XPAR:AELIS) Business Description

Traded in Other Exchanges
Address
146, rue Leo Saignat, Bordeaux, FRA, 33077
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.

Aelis Farma (XPAR:AELIS) Headlines

No Headlines